Loading...
Inactivation of Sox9 in fibroblasts reduces cardiac fibrosis and inflammation
Scharf, Gesine M. Scharf, G. Kilian, Katja Cordero, Julio Wang, Yong Grund, Andrea Hofmann, Melanie Froese, Natali Wang, Xue Kispert, Andreas
Scharf, Gesine M.
Scharf, G.
Kilian, Katja
Cordero, Julio
Wang, Yong
Grund, Andrea
Hofmann, Melanie
Froese, Natali
Wang, Xue
Kispert, Andreas
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2019-08-08
Submitted date
Other Titles
Abstract
Fibrotic scarring drives the progression of heart failure after myocardial infarction (MI). Therefore, the development of specific treatment regimens to counteract fibrosis is of high clinical relevance. The transcription factor SOX9 functions as an important regulator during embryogenesis, but recent data point towards an additional causal role in organ fibrosis. We show here that SOX9 is upregulated in the scar after MI in mice. Fibroblast specific deletion of Sox9 ameliorated MI-induced left ventricular dysfunction, dilatation and myocardial scarring in vivo. Unexpectedly, deletion of Sox9 also potently eliminated persisting leukocyte infiltration of the scar in the chronic phase after MI. RNA-sequencing from the infarct scar revealed that Sox9 deletion in fibroblasts resulted in strongly downregulated expression of genes related to extracellular matrix, proteolysis and inflammation. Importantly, Sox9 deletion in isolated cardiac fibroblasts in vitro similarly affected gene expression as in the cardiac scar and reduced fibroblast proliferation, migration and contraction capacity. Together, our data demonstrate that fibroblast SOX9 functions as a master regulator of cardiac fibrosis and inflammation and might constitute a novel therapeutic target during MI.
Citation
JCI Insight. 2019 Jul 16;5. pii: 126721. doi: 10.1172/jci.insight.126721.
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
15
ISSN
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution-NonCommercial-ShareAlike 4.0 International